Anúncio
Anúncio

JNJ

JNJ logo

Johnson & Johnson

207.49
USD
Patrocinado
+2.69
+1.31%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pré-Mercado

206.93

-0.56
-0.27%

Relatórios de Lucros JNJ

Rácio de surpresa positiva

JNJ separação 34 de 39 últimas estimativas.

87%

Próximo Relatório

Data do Próximo Relatório
21 de jan. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$24.37B
/
$2.55
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+1.57%
/
-8.93%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+8.22%
/
+25.00%

Johnson & Johnson earnings per share and revenue

On 14 de out. de 2025, JNJ reported earnings of 2.80 USD per share (EPS) for Q3 25, beating the estimate of 2.78 USD, resulting in a 0.55% surprise. Revenue reached 23.99 bilhão, compared to an expected 23.99 bilhão, with a 0.03% difference. The market reacted with a -0.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of 2.55 USD, with revenue projected to reach 24.37 bilhão USD, implying an diminuir of -8.93% EPS, and aumentar of 1.57% in Revenue from the last quarter.
FAQ
For Q3 2025, Johnson & Johnson reported EPS of $2.80, beating estimates by 0.55%, and revenue of $23.99B, 0.03% above expectations.
The stock price moved down -0.03%, changed from $190.90 before the earnings release to $190.85 the day after.
The next earning report is scheduled for 21 de jan. de 2026.
Based on 18 analistas, Johnson & Johnson is expected to report EPS of $2.55 and revenue of $24.37B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio